Safety and efficacy of allylamines in the treatment of cutaneous and mucocutaneous leishmaniasis: A systematic review. [PDF]
Cutaneous and mucocutaneous leishmaniasis affect a million people yearly, leading to skin lesions and potentially disfiguring mucosal disease. Current treatments can have severe side effects. Allylamine drugs, like terbinafine, are safe, including during
Jacob M Bezemer +4 more
doaj +3 more sources
Atypical Mucocutaneous Leishmaniasis Presentation Mimicking Rectal Cancer [PDF]
Cutaneous leishmaniasis is a neglected tropical disease affecting mostly the exposed skin, causing severe and disfiguring lesions in Ethiopia. In this report, we present two cases of atypical mucocutaneous leishmaniasis; one HIV positive and one HIV ...
Helina Fikre +6 more
doaj +4 more sources
Progress of Mucocutaneous Leishmaniasis to Drug Nonresponsive Diffuse Cutaneous Leishmaniasis in Ethiopia. A Case Report [PDF]
Banchamlak Tegegne,1 Getaneh Alemu2 1Amhara Public Health Institute, Bahir Dar, Ethiopia; 2Department of Medical Laboratory Science, Bahir Dar University, Bahir Dar, EthiopiaCorrespondence: Getaneh Alemu PO Box 79 Tel +251922842776Email getanehmlt@gmail ...
Tegegne B, Alemu G
doaj +4 more sources
Differentiation of mucosal lesions in mucocutaneous leishmaniasis and paracoccidioidomycosis. [PDF]
Mucocutaneous leishmaniasis and paracoccidioidomycosis are infectious diseases with similar epidemiological and clinical aspects. Cases of both diseases may manifest similar lesions in the mucosa.
Creuza Rachel Vicente, Aloisio Falqueto
doaj +4 more sources
Pentavalent Antimonials Combined with Other Therapeutic Alternatives for the Treatment of Cutaneous and Mucocutaneous Leishmaniasis: A Systematic Review [PDF]
The first choice drugs for the treatment of cutaneous and mucocutaneous leishmaniasis are pentavalent antimonials, sodium stibogluconate, or meglumine antimoniate.
Taisa Rocha Navasconi Berbert +10 more
doaj +4 more sources
Mucocutaneous Leishmaniasis/HIV Coinfection Presented as a Diffuse Desquamative Rash [PDF]
Leishmaniasis is an infectious disease that is endemic in tropical areas and in the Mediterranean. This condition spreads to 98 countries in four continents, surpassing 12 million infected individuals, with 350 million people at risk of infection.
Guilherme Almeida Rosa da Silva +7 more
doaj +2 more sources
Successful treatment by adding thalidomide to meglumine antimoniate in a case of refractory anthroponotic mucocutaneous leishmaniasis [PDF]
Mucosal leishmaniasis (ML) is mostly associated with Leishmania braziliensis; however, a few cases of Leishmania tropica induced mucocutaneous leishmaniasis have been reported.
Vahid Mashayekhi Goyonlo +2 more
doaj +2 more sources
Mucocutaneous Leishmaniasis in a Pregnant Immigrant. [PDF]
Abstract Cutaneous leishmaniasis is a parasitic infection that causes significant maternal morbidity, and even fetal mortality, during pregnancy, yet there are limited therapeutic options. Here, we report a case of leishmaniasis in a pregnant immigrant with exuberant mucocutaneous lesions with favorable response to liposomal amphotericin
Briggs N +16 more
europepmc +3 more sources
Treatment strategies for mucocutaneous leishmaniasis
Mucocutaneous is an infection caused by a single celled parasite transmitted by sand fly bites. There are about 20 species of Leishmania that may cause mucocutaneous leishmaniasis.
Emilio Palumbo
doaj +3 more sources
Mucocutaneous leishmaniasis: case report and literature review of a rare endonasal infection [PDF]
Leishmaniasis is a protozoal infection transmitted by a sandfly vector. In Germany leishmaniasis of the mucous membranes is a rare condition and usually due to extension of local skin disease into the mucosal tissue via direct extension, bloodstream or ...
Abrar Adnan Suqati +2 more
doaj +2 more sources

